JAAD CME Supplement – Hidradenitis Suppurativa: Embracing Progress

To read the full JAAD Supplements click here.

Hidradenitis suppurativa care has advanced rapidly, with deeper insight into its pathogenesis and expanding treatment options. This CME supplement covers epidemiology, disease drivers, severity assessment, and the full treatment landscape, from biologics to procedural approaches and pain management. Build a comprehensive framework for evaluating and managing hidradenitis suppurativa across the patient journey.

Summary

Availability:

On-Demand

Access expires on Dec 01, 2027

Credit Offered:

11 CME Credits

Recommended

Question of the Week Self-Assessment - 2026

13.25 CME

JAAD 11/25 Hand Eczema. Part 1: Epidemiology, pathogenesis, diagnosis and work-up

Multiple Credits

JAAD 12/25 Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis

Multiple Credits

JAAD 10/25 Clinical consequences of age-related skin barrier dysfunction Part I. Structural, molecular and physiologic changes with cutaneous aging

Multiple Credits

JAAD 11/25 Hand Eczema. Part 2: Prevention, management, and treatment

Multiple Credits

JAAD 12/25 Lentigo Maligna Part II: Management

Multiple Credits

JAAD 10/25 Clinical consequences of age-related skin barrier dysfunction Part II. Approach to barrier dysfunction in the geriatric population

Multiple Credits

JAAD 01/26 Augmented Intelligence and Dermatology - Part I: Core Concept and Applications

AI is transforming dermatology, but are you ready to use it wisely? This CME activity breaks down the essentials, from how AI models are built to where bias, ethics, and regulation come into play. Learn to speak the language of AI and critically evaluate the tools shaping the future of skin care.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Molecular Profile, Clinical Presentation, and Diagnosis

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME

JAAD 04/26 Frontal Fibrosing Alopecia (FFA) Part I - Diagnosis and Clinical Presentation

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME